What is the HIFU procedure and under what conditions would I choose this option?

The HIFU procedure for prostate tissue ablation uses an ultrasound probe to scan the prostate and deliver high-intensity sound waves directed at the target area — similar to how a magnifying glass can focus the rays of the sun to burn a leaf. This concentration of ultrasound waves raises the temperature at the focal point, causing coagulation necrosis (cell damage and death), without damaging the surrounding healthy tissue and structures. The HIFU procedure is non-invasive (no incision – no radiation) and an effective option for prostate ablation with low occurrence of side effects.

The HIFU procedure is repeatable and can also be used after an initial therapy on the prostate.

Focal One® and high intensity focused ultrasound

Thanks to the latest medical device in the HIFU range, the Focal One®, the urologist can now decide to offer focal ablation if the characteristics of the affected prostate and patient’s choices allow for it. This therapeutic approach aims to control the disease by closely monitoring the patient and repeating the treatment if necessary. This innovative procedure is currently being investigated and initial results show a perfect preservation of sexual and urinary functions. Focal ablation is an alternative option between active surveillance and radical treatments; diseased portion of the prostate is effectively ablated but via a minimally invasive process preserving the patients quality of life while suppressing the psychological stress generated by active surveillance.[1; 2]Only your urologist can tell you which treatment is right for you depending on the characteristics of your condition.


[1] A Abreu, et al. (2020). High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series. Journal of Urology, 204(4), 741-747. https://doi.org/10.1097/JU.0000000000001126 

[2] B Nahar, et al. (2020). Prospective Evaluation of Focal High Intensity Focused Ultrasound for Localized Prostate Cancer. Journal of Urology. 204(3). 483-489. https://doi.org/10.1097/JU.0000000000001015 

Similar questions